2021
DOI: 10.3390/cells10112916
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines

Abstract: Gene mutations in PIK3CA, PIK3R1, KRAS, PTEN, and PPP2R1A commonly detected in type I endometrial cancer lead to PI3K/Akt/mTOR pathway activation. Bimiralisib (PQR309), an orally bioavailable selective dual inhibitor of PI3K and mTOR, has been studied in preclinical models and clinical trials. The aim of this study is to evaluate the anticancer effect of PQR309 on endometrial cancer cells. PQR309 decreased cell viability in two-dimensional and three-dimensional cell culture models. PQR309 induced G1 cell cycle… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 45 publications
3
17
0
Order By: Relevance
“…A previous study found that the activation of PI3K-Akt and P53 signaling pathways had a very high risk of EC progression. [ 21 ] In the Rap1 signaling pathway, Rap1GAP can act as a tumor suppressor inhibiting the Ras superfamily protein Rap1 in EC, and it is an independent prognostic factor in EC. [ 22 ] EGFR tyrosine kinase inhibitor is a small molecule EGFR inhibitor that can inhibit tyrosine kinase activation, block the EGFR signaling pathway, inhibit the proliferation and metastasis of tumor cells, and promote apoptosis through competitive endogenous ligand binding to EFGR.…”
Section: Discussionmentioning
confidence: 99%
“…A previous study found that the activation of PI3K-Akt and P53 signaling pathways had a very high risk of EC progression. [ 21 ] In the Rap1 signaling pathway, Rap1GAP can act as a tumor suppressor inhibiting the Ras superfamily protein Rap1 in EC, and it is an independent prognostic factor in EC. [ 22 ] EGFR tyrosine kinase inhibitor is a small molecule EGFR inhibitor that can inhibit tyrosine kinase activation, block the EGFR signaling pathway, inhibit the proliferation and metastasis of tumor cells, and promote apoptosis through competitive endogenous ligand binding to EFGR.…”
Section: Discussionmentioning
confidence: 99%
“…S6K2 inhibitor induces G1 arrest to inhibit the proliferation of melanoma cells [ 291 ]. PI3K/mTOR inhibitor PQR309 inhibits the PI3K/AKT/mTOR/c-Myc axis and causes G1 arrest of endometrial cancer cells [ 265 ]. Mature SREBP1 is regulated by hyperphosphorylation for G2/M arrested cervical cancer cells [ 301 ].…”
Section: Akt Effectors Modulate Cell Functionsmentioning
confidence: 99%
“…The PI3K/AKT/mTOR pathway can inhibit autophagy [14]. In addition, FAM83D contributed to the progression of several cancers via this pathway [13,14]. Previous studies confirmed FAM83D had effects on the PI3K/AKT/mTOR axis, which could further affect multiple cellular processes in cancer progression, such as proliferation, apoptosis, and autophagy [12,15].…”
Section: Introductionmentioning
confidence: 98%
“…Activation of phosphoinositol 3-kinase (PI3K) or mTOR is the most common event in the development of human cancers, including EC [12]. The alteration of PI3K/AKT/mTOR pathway is related to the pathogenesis of endometrial carcinoma [13]. The PI3K/AKT/mTOR pathway can inhibit autophagy [14].…”
Section: Introductionmentioning
confidence: 99%